YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer.

YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer. Clin Cancer Res. 2019 04 01; 25(7):2264-2277.

View in: PubMed

subject areas

Adaptor Proteins, Signal Transducing
Animals
Cell Cycle
Cell Line, Tumor
Combined Modality Therapy
Cyclin-Dependent Kinase 6
Disease Models, Animal
Drug Resistance, Neoplasm
Esophageal Neoplasms
Gene Expression
Gene Knockout Techniques
Genes, Reporter
Humans
Immunohistochemistry
Mice
Models, Biological
Neoplastic Stem Cells
Protein Binding
Protein Kinase Inhibitors
Radiation Tolerance
Transcription Factors
Xenograft Model Antitumor Assays

authors with profiles

Pankaj Kumar Singh